PhD Priscilla F. McAuliffe MD

Suggest Changes
Learn More
Neoadjuvant chemotherapy (NAC) downstages axillary disease in 55 % of node-positive (N1) breast cancer. The feasibility and accuracy of sentinel lymph node biopsy (SLNB) after NAC for percutaneous(More)
  • 1